In Black South Africans from Rural and Urban Communities, the 4G/5G PAI-1 Polymorphism Influences PAI-1 Activity, but Not Plasma Clot Lysis Time

被引:6
|
作者
de Lange, Zelda [1 ]
Rijken, Dingeman C. [2 ]
Hoekstra, Tiny [1 ,3 ]
Conradie, Karin R. [1 ]
Jerling, Johann C. [1 ]
Pieters, Marlien [1 ]
机构
[1] North West Univ, Ctr Excellence Nutr, Potchefstroom, South Africa
[2] Erasmus Univ, Med Ctr, Dept Haematol, Rotterdam, Netherlands
[3] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands
来源
PLOS ONE | 2013年 / 8卷 / 12期
基金
英国医学研究理事会; 新加坡国家研究基金会;
关键词
PLASMINOGEN-ACTIVATOR INHIBITOR-1; MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE; VENOUS THROMBOSIS; INCOME COUNTRIES; CORONARY ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; CIRCULATING LEVELS; METABOLIC SYNDROME; ADIPOSE-TISSUE;
D O I
10.1371/journal.pone.0083151
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Data on genetic and environmental factors influencing PAI-1 levels and their consequent effect on clot lysis in black African populations are limited. We identified polymorphisms in the promoter area of the PAI-1 gene and determined their influence on PAI-1(act) levels and plasma clot lysis time (CLT). We also describe gene-environment interactions and the effect of urbanisation. Data from 2010 apparently healthy urban and rural black participants from the South African arm of the PURE study were cross-sectionally analysed. The 5G allele frequency of the 4G/5G polymorphism was 0.85. PAI-1(act) increased across genotypes in the urban subgroup (p = 0.009) but not significantly in the rural subgroup, while CLT did not differ across genotypes. Significant interaction terms were found between the 4G/5G polymorphism and BMI, waist circumference and triglycerides in determining PAI-1(act), and between the 4G/5G polymorphism and fibrinogen and fibrinogen gamma prime in determining CLT. The C428T and G429A polymorphisms did not show direct relationships with PAI-1(act) or CLT but they did influence the association of other environmental factors with PAI-1(act) and CLT. Several of these interactions differed significantly between rural and urban subgroups, particularly in individuals harbouring the mutant alleles. In conclusion, although the 4G/5G polymorphism significantly affected PAI-1(act), it contributed less than 1% to the PAI-1(act) variance. (Central) obesity was the biggest contributor to PAI-1(act) variance (12.5%). Urbanisation significantly influenced the effect of the 4G/5G polymorphism on PAI-1(act) as well as gene-environment interactions for the C428T and G429A genotypes in determining PAI-1(act) and CLT.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] The Role of PAI-1 4G/5G Promoter Polymorphism and Its Levels in the Development of Ischemic Stroke in Young Indian Population
    Akhter, Mohammad Suhail
    Biswas, Arijit
    Abdullah, Saleh Mohammed
    Behari, Madhuri
    Saxena, Renu
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2017, 23 (08) : 1071 - 1076
  • [22] Association between PAI-1 4G/5G Polymorphisms and osteonecrosis of femoral head: A Meta-analysis
    Liang, Xiao-Nan
    Xie, Li
    Cheng, Jian-Wen
    Tan, Zhen
    Yao, Jun
    Liu, Qian
    Su, Wei
    Qin, Xue
    Zhao, Jin-Min
    THROMBOSIS RESEARCH, 2013, 132 (02) : 158 - 163
  • [23] Anterior ischemic optic neuropathy comorbid with Factor V Leiden and PAI-1 4G/5G mutation
    Titlic, M.
    Karaman, K.
    Andelinovic, S.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2009, 110 (03): : 192 - 194
  • [24] Correlation Between PAI-1 Gene 4G/5G Polymorphism and the Risk of Thrombosis in Ph Chromosome-Negative Myeloproliferative Neoplasms
    Zhang, Xueya
    Cai, Xuerong
    Pan, Jingxin
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2020, 26
  • [25] PAI-1 4G/5G Polymorphism is Associated with Brain Vessel Reocclusion After Successful Fibrinolytic Therapy in Ischemic Stroke Patients
    Fernandez-Cadenas, I.
    Del Rio-Espinola, A.
    Rubiera, M.
    Mendioroz, M.
    Domingues-Montanari, S.
    Cuadrado, E.
    Hernandez-Guillamon, M.
    Rosell, A.
    Ribo, M.
    Alvarez-Sabin, J.
    Molina, C. A.
    Montaner, J.
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2010, 120 (04) : 245 - 251
  • [26] PAI-1 5G/5G genotype is an independent risk of intracranial hemorrhage in post-lysis stroke patients
    Szegedi, Istvan
    Nagy, Attila
    Szekely, Edina G.
    Czuriga-Kovacs, Katalin R.
    Sarkady, Ferenc
    Lanczi, Levente, I
    Berenyi, Ervin
    Csiba, Laszlo
    Bagoly, Zsuzsa
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (11): : 2240 - 2250
  • [27] Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome
    Sales, M. F.
    Soter, M. O.
    Candido, A. L.
    Fernandes, A. P.
    Oliveira, F. R.
    Ferreira, A. C. S.
    Sousa, M. O.
    Ferreira, C. N.
    Gomes, K. B.
    GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (10) : 936 - 939
  • [28] PAI-1 4G/5G and ACE I/D gene polymorphisms and the occurrence of myocardial infarction in patients on intermittent dialysis
    Aucella, F
    Margaglione, M
    Vigilante, M
    Gatta, G
    Grandone, E
    Forcella, M
    Ktena, M
    De Min, A
    Salatino, G
    Procaccini, DA
    Stallone, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (06) : 1142 - 1146
  • [29] Increase in plasma plasminogen activators inhibitor type 1 concentration after fibrinolytic treatment in patients with acute myocardial infarction is associated with 4G/5G polymorphism of PAI-1 gene
    Mlynarska, A.
    Waszyrowski, T.
    Kasprzak, J. D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (06) : 1361 - 1366
  • [30] Myocardial infarction and arterial thrombosis in identical newborn twins with homozygosity for the PAI-1 4 G/5 G polymorphism
    De Lucia, Vittoria
    Andreassi, Maria Grazia
    Sabatini, Laura
    Ait-Ali, Lamia
    Spadoni, Isabella
    Giusti, Sandra
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 137 (01) : E1 - E4